Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 8Pain, Postoperative 4Chronic Pain 3Agnosia 3Stomach Neoplasms 1Rectal Neoplasms 1Pain 1Myofibroma 1Multiple Pulmonary Nodules 1Maxillofacial Tumors 1Leiomyoma 1Ileus 1Colorectal Neoplasms 1Colonic Neoplasms 1Breast Cancer Surgery 1Abdominal Cancer 1Abdomen, Acute 1

Interventions

Misoprostol 5Uterine Myomectomy 3Saline Solution 3relugolix 2dienogest 2carbetocin 2Uterine Artery Embolization 2Tranexamic Acid 2Tourniquets 2Lidocaine 2Leuprolide 2Ascorbic Acid 2ulipristal 1telapristone acetate 1ramosetron 1pirfenidone 1estradiol, norethindrone drug combination 1Vasopressins 1Triptorelin Pamoate 1Tablets 1Sodium Chloride 1Sevoflurane 1Respiration, Artificial 1Remifentanil 1Propofol 1Population Groups 1Oxytocin 1Nuclear Receptor Subfamily 4, Group A, Member 2 1Morcellation 1Methylergonovine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Myofibroma × Anesthetics, Local × Clear all
NCT02293447 2016-05-12

Intra-arterial Lidocaine for Pain Control Post Uterine Fibroid Embolization

University Health Network, Toronto

Phase 4 Completed
60 enrolled

Leiomyoma, Pain, Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡